Delivery Order SPE2DB20D2104-SPE2DB21FT43F
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) and is a Delivery Order valued at $1,428.48. The contract is for the delivery of 4556513017 - NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 10, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUCYNTA 100 MG TABLET 100S. The order, valued at $6,661.62, is a firm fixed-price contract with a completion date of May 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and other federal healthcare programs. The specific delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,740.54 firm fixed-price delivery order is for the supply of NUCYNTA ER 100 MG tablets. The contract has an ultimate completion date of February 15, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp is a $1,837.56 firm fixed-price delivery order from the Defense Logistics Agency (DLA), a defense agency. The contract is not set aside and provides for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, with a period of performance through June 13, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for the supply of NUCYNTA 100 mg tablets. The $6,304.16 order has a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical and medical products and distribution services in support of military treatment programs and facilities....
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The award has a potential value of $14,825.16 and a completion date of February 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,885.39 firm fixed-price delivery order is for NUCYNTA TABS 50MG, a pain management medication. The contract has an ultimate completion date of January 16, 2024 and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of NUCYNTA TABS 50MG to the U.S. government. The contract has a Firm Fixed Price (FFP) pricing type and a ceiling value of $8,968.12, with a period of performance through February 15, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major pharmaceutical distributor that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NUCYNTA 50 MG TABLET 100S. The $1,014.40 firm fixed price delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FT43FDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,053.51 for the supply of NUCYNTA 100 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense, and has an ultimate completion date of July 27, 2021. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities to support military healthcare programs globally. Additionally, Cencora, Inc. maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/26/21 |